Gadofosveset
![]() | |
| Clinical data | |
|---|---|
| Trade names | Vasovist, Ablavar |
| Pregnancy category |
|
| Routes of administration | Intravenous |
| ATC code | V08CA11 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
211570-55-7 193901-90-5 (anhydrous) |
| PubChem (CID) | 158440 |
| DrugBank | DB06705 |
| ChemSpider | 139381 |
| UNII |
XM33Q67UVH |
| KEGG |
D08005 |
| Chemical and physical data | |
| Formula | C33H40GdN3Na3O15P |
| Molar mass | 975.88 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It is used as the trisodium salt monohydrate form.[1][2] It acts as a blood pool agent by binding to human serum albumin.
References
This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
